Harmony Biosciences Holdings Inc

-1.59 (-4.63%)
7:52:22 PM EDT: $32.80 +0.03 (+0.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.88B
Current PE9.36
Forward PE 13.06
2yr Forward PE 9.61
See more stats
Estimates Current Quarter
Revenue$148.08 Million
Adjusted EPS$0.67
See more estimates
10-Day MA$34.73
50-Day MA$34.70
200-Day MA$39.41
See more pivots

Harmony Biosciences Holdings Inc Stock, NASDAQ:HRMY

630 West Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania 19462
United States of America
Phone: +1.484.539.9800
Number of Employees: 200


Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.